CAI FY 2008 Earnings — Caris Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena

CAICaris Life Sciences, Inc.

$5B

FY 2008 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$83M+28.2% YoY

Gross Profit

$78M94.1% margin

Operating Income

$44M53.3% margin

Net Income

-$27M-32.4% margin

EPS (Diluted)

$-1.55

Cash Flow

Operating Cash Flow

$27M

Free Cash Flow

-$177M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$413M

Total Liabilities

$299M

Stockholders' Equity

$114M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$83M	$65M	+28.2%
Gross Profit	$78M	$61M	+28.7%
Operating Income	$44M	$40M	+10.9%
Net Income	-$27M	$19M	-240.1%